American Bio Medica Corporation (ABMC)

Market Cap	913.87K
Revenue (ttm)	1.25M
Net Income (ttm)	-1.42M
Shares Out	48.10M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	443,200
Open	0.0130
Previous Close	0.0111
Day's Range	0.0110 - 0.0190
52-Week Range	0.0100 - 0.0400
Beta	-0.69
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About ABMC

American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detec...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Dec 24, 1997
• Employees: 32
• Stock Exchange: OTCMKTS
• Ticker Symbol: ABMC

Financial Performance

In 2021, ABMC's revenue was $2.22 million, a decrease of -46.52% compared to the previous year's $4.15 million. Losses were -$463,000, -41.83% less than in 2020.